PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 46 filers reported holding PASSAGE BIO INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 4,959,769 | $15,375,000 | 15.35% |
HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,235,869 | $3,831,000 | 4.65% |
New Leaf Venture Partners, L.L.C. | 2,497,922 | $7,744,000 | 3.82% |
Frazier Life Sciences Management, L.P. | 5,009,219 | $15,529,000 | 1.32% |
Deep Track Capital, LP | 3,375,000 | $10,463,000 | 0.67% |
Orbimed Advisors | 7,331,999 | $22,729,000 | 0.37% |
Lynx1 Capital Management LP | 105,504 | $327,000 | 0.30% |
XTX Topco Ltd | 94,309 | $292,000 | 0.13% |
Woodline Partners LP | 1,913,880 | $5,933,000 | 0.10% |
GREAT POINT PARTNERS LLC | 113,900 | $353,000 | 0.08% |